Gmelina asiatica
Gmelina asiatica · Accepted scientific name
Scientific literature: Very Sparse (2 studies) · ★☆☆☆☆
Gmelina asiatica is a botanical species that has garnered significant scientific interest due to its diverse pharmacological potential. Recent studies have focused on the bioactive properties of the plant, particularly regarding its cytotoxic and anticancer activities. Research specifically highlights the efficacy of ethanolic extracts of roots in addressing serious conditions such as breast cancer, cervical cancer, and lymphoma. Furthermore, the plant's leaves and root preparations have demonstrated meaningful impact in combatting pathogens like Escherichia coli. Consequently, exploring these medicinal components offers promising avenues for future therapeutic developments.
- Synonyms
- Gmelina Elliptica F. Lobata · Gmelina Parvifolia · 7 more
- Common names
- Not available
- Family
- Lamiaceae
- Distribution
- Not available
- Plant Parts
- Root · Leaf
Classification
Synonyms
Gmelina asiatica is a taxonomically complex species that is associated with several important botanical synonyms. Within its scientific classification, it is linked to Bignonia moluccana as well as Gmelina attenuata. The plant also encompasses various forms, specifically Gmelina asiatica f. lobata and Gmelina asiatica f. parvifolia. Furthermore, the synonym Gmelina elliptica f. lobata is frequently cited in relation to this species. Understanding these various naming conventions is essential for accurate botanical identification and study.
Sources: The World Checklist of Vascular Plants (WCVP)
Taxonomy
Gmelina asiatica belongs to the diverse kingdom Plantae, marking its place within the vast world of living vegetation. This specific species is classified under the class Equisetopsida, distinguishing its fundamental biological structure. Within the taxonomic hierarchy, it is categorized under the order Lamiales, which helps scientists understand its evolutionary lineage. It further belongs to the family Lamiaceae, a group known for many distinct botanical characteristics. Ultimately, this plant is a proud member of the genus Gmelina, which defines its unique identity among other species.
| Rank | Classification |
|---|---|
| Kingdom | Plantae |
| Phylum | Streptophyta |
| Class | Equisetopsida |
| Subclass | Magnoliidae |
| Order | Lamiales |
| Family | Lamiaceae |
| Genus | Gmelina |
Sources: The World Checklist of Vascular Plants (WCVP)
Distribution
Geographic Regions
Gmelina asiatica is a widely distributed species found throughout the tropical regions of Asia. Within the Indian Subcontinent, this plant flourishes across the diverse landscapes of India, Bangladesh, and Sri Lanka. Its range extends further into Indo-China, where it can be found in countries such as Cambodia. Additionally, the species is native to the unique ecosystems of the Andaman Islands. This broad geographic spread highlights the plant's adaptability to various tropical environments across the continent.
Sources: The World Checklist of Vascular Plants (WCVP)
Identification
Morphology
Gmelina asiatica typically adopts a shrub-like growth form as it develops. This plant is naturally self-supporting, allowing it to maintain its structure without the need for external assistance.
Sources: Global Inventory of Floras and Traits (GIFT)
Biological Activities
Gmelina asiatica has emerged as a significant medicinal plant due to its diverse biological activities and therapeutic potential. Recent research highlights its potent anticancer properties, which have already been demonstrated against breast cancer and lymphoma in existing literature. Specifically, new studies investigating its leaf extracts have shown remarkable efficacy against the SiHa cervical cancer cell line. Through both in-vitro and in-silico evaluations, the plant has displayed strong cytotoxic activity, particularly with its methanolic extract. These findings suggest that Gmelina asiatica serves as a promising natural source for developing new molecules to combat resistant cancer types.
Compounds
Conditions
Gmelina asiatica demonstrates significant antimicrobial activity against several pathogenic bacteria, including Escherichia coli, Proteus vulgaris, and Pseudomonas aeruginosa. Research indicates that the root extracts of this plant also exhibit prominent oral antipyretic activity. Beyond its ability to combat infection and fever, the plant possesses notable anticancer potential. Specifically, existing literature has demonstrated the effectiveness of Gmelina asiatica in treating breast cancer. These diverse biological activities highlight its value as a versatile medicinal resource.
Preparations
Gmelina asiatica is prepared as ethanolic extracts of its roots to evaluate specific medicinal properties. These root extracts are tested for their potential antimicrobial activity against various pathogens. The study focuses on how these prepared extracts interact with bacteria like Escherichia coli and Proteus vulgaris. By utilizing the ethanolic extraction method, researchers can isolate compounds from the roots for testing. This specific preparation serves as a key component in assessing the plant's broad spectrum of antimicrobial effectiveness.
Parts used
Gmelina asiatica is a versatile medicinal plant that offers significant therapeutic potential through its various anatomical components. Research has demonstrated that the roots of this species possess prominent antipyretic activity and exhibit a broad spectrum of antimicrobial properties. Furthermore, the leaves of the plant are being extensively studied for their potent anticancer capabilities, particularly against cervical cancer cell lines. By utilizing different parts of the plant, such as the roots and leaves, scientists are uncovering new strategies for treating infectious and oncogenic diseases. These findings highlight the importance of Gmelina asiatica as a rich natural source for developing novel pharmaceutical compounds.